The Scientist

» biotech

Most Recent

Jazz Pharmaceuticals is set to purchase Celator to acquire an experimental treatment for acute myeloid leukemia.

1 Comment

image: Biotech Sponsors Science Competition

Biotech Sponsors Science Competition

By | May 26, 2016

Regeneron Pharmaceuticals takes over from Intel as the sponsor of the Science Talent Search.

0 Comments

image: Report: Still Lots to Learn About GE Crops

Report: Still Lots to Learn About GE Crops

By | May 17, 2016

A National Academies–led analysis evaluates the impacts of genetically engineered crops—and calls for updated regulations.

1 Comment

image: Another Gene-Editing IPO

Another Gene-Editing IPO

By | April 12, 2016

Intellia Therapeutics, which seeks to develop CRISPR-based technologies to target rare diseases, is hoping to raise $120 million in an initial public offering.

0 Comments

image: Inaccurate Cholesterol Tests from Theranos

Inaccurate Cholesterol Tests from Theranos

By | March 29, 2016

The company’s finger-prick tests yield cholesterol levels notably lower than results of traditional blood draw tests from two other large companies, according to a study.

0 Comments

image: Science Exchange Raises $25M

Science Exchange Raises $25M

By | March 24, 2016

With fresh funding, the experiment-services and independent-validation startup will expand its staff.

0 Comments

image: Cannabis-Based Drug for Epilepsy

Cannabis-Based Drug for Epilepsy

By | March 14, 2016

A marijuana-derived compound shows continued success in treating children with a rare form of the seizure disorder. 

0 Comments

image: TS Picks: December 30, 2015

TS Picks: December 30, 2015

By | December 30, 2015

Overvaluing startups; undervaluing human research participants; curing aging?

0 Comments

image: Following FDA OK, 23andMe to Expand Health Prediction

Following FDA OK, 23andMe to Expand Health Prediction

By | October 21, 2015

The personal genomics firm is ramping up its suite of disease-related genetic tests.

0 Comments

image: Gene-Edited Pets

Gene-Edited Pets

By | October 2, 2015

Genomics giant BGI announces plans to sell “micro-pigs” it originally developed for research.

1 Comment

Popular Now

  1. Opinion: Why I Published in a Predatory Journal
    News & Opinion Opinion: Why I Published in a Predatory Journal

    My “colleagues” and I at the fictitious Arthur Vandelay Urological Research Institute were surprised to find our bogus “uromycitisis” case report swiftly accepted, with only minor revisions requested.

  2. Consilience, Episode 3: Cancer, Obscured
  3. A History of Screening for Natural Products to Fight Cancer
  4. March for Science: Dispatches from Washington, DC
AAAS